Takuma Hayashi | Oncology Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Takuma Hayashi | Oncology Pharmaceuticals | Best Researcher Award

Prof. Dr. Takuma Hayashi, National Hospital Organization Kyoto Medical Center, Japan

Prof. Dr. Takuma Hayashi is a renowned Japanese physician-scientist specializing in gynecologic oncology. 🎓 He earned his PhD from the University of Tokyo and trained at MIT’s Whitehead Institute 🧠, contributing to Nobel-linked research. Currently a professor at Shinshu University and Section Head at Kyoto Medical Center 🏥, his groundbreaking work on uterine leiomyosarcoma (LMS) identified LMP2 deficiency as a key biomarker 🔎. Through precision medicine and genomic profiling 🧬, his research has significantly advanced diagnostics and treatment strategies for LMS. With over 30 years of funded research, Dr. Hayashi is globally recognized for revolutionizing women’s cancer care.

Publication Profile

Scopus

Education

Prof. Dr. Takuma Hayashi is a distinguished physician-scientist known for bridging fundamental cancer research with clinical applications. 👨‍⚕️🔬 He is a Professor at Shinshu University Graduate School of Medicine and Section Head at Japan’s National Hospital Organization Kyoto Medical Center. 🎓🏥 Dr. Hayashi earned his PhD from the University of Tokyo and completed postdoctoral training at MIT’s Whitehead Institute under Dr. Rick A. Young. 🎓🇯🇵🇺🇸 He contributed to Nobel Prize-linked AIDS vaccine research with Dr. David Baltimore. With over 30 years of NIH and JSPS funding, his work focuses on molecular research in uterine leiomyosarcoma and ovarian cancer, collaborating with Nobel Laureate Dr. Susumu Tonegawa.

Experience

Prof. Dr. Takuma Hayashi has pioneered precision medicine breakthroughs in uterine leiomyosarcoma (LMS) treatment. 🧬💉 His team used cancer genome panel testing to tailor therapies based on each tumor’s unique genetics. For example, immunotherapy with pembrolizumab led to significant tumor regression, while targeted treatment with pazopanib stabilized disease for months. 🎯💊 Dr. Hayashi’s background from the University of Tokyo and MIT supports his innovative approach. 🚀 His ongoing goals include developing diagnostics, launching clinical trials, expanding global collaboration, and improving patient access to genomic profiling. 🌍💡 His work offers new hope for women facing this aggressive cancer.

Research Focus

Prof. Dr. Takuma Hayashi’s research primarily focuses on molecular oncology and infectious diseases, particularly cancer biomarkers and viral infections. 🧬🔬 His work on uterine leiomyosarcoma involves discovering key diagnostic biomarkers like LMP2 to improve early detection and treatment strategies in aggressive cancers. 🩺🎗️ Additionally, Dr. Hayashi explores infectious diseases such as avian influenza and COVID-19, emphasizing the One Health approach to prevent viral spread between animals and humans. 🦠🌍 His interdisciplinary research bridges cancer biology, immunology, and public health, aiming to develop precision medicine therapies and enhance global disease control efforts.

Publication Top Notes

THE ROLE OF LIVE BIRD MARKETS SHOULD BE EMPHASIZED IN PREVENTING THE SPREAD OF HIGHLY PATHOGENIC AVIAN INFLUENZA INFECTIONS

THE IMPORTANCE OF ONE HEALTH IN PREVENTING THE SPREAD OF HIGHLY PATHOGENIC AVIAN INFLUENZA/H5N1

Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer

DEVELOPMENT OF ENDOSALPINGIOSIS IN PATIENTS WITH A HISTORY OF BREAST CANCER

High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study

POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY

Assoc Prof Dr. Sanli Jin| Oncology Pharmaceuticals |Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Sanli Jin|Oncology Pharmaceuticals|Best Researcher Award

Assoc Prof Dr. Sanli Jin at Peking University School of Nursing,China

PROFILE  

scopus

Early Academic Pursuits 🎓

Sanli Jin embarked on her academic journey at Peking University, one of the most prestigious institutions in China. After joining the School of Nursing in 2004, she pursued her doctoral degree with a specific focus on oncology and nutrition nursing, surgical nursing, and nursing simulation. Her early years of academic training at Peking University provided her with a strong foundation in both theoretical knowledge and practical skills. This combination of educational rigor and practical exposure positioned her to become a leader in the field of nursing education in China.

Professional Endeavors 👩‍🏫

Since completing her doctoral studies, Sanli Jin has been an integral member of the School of Nursing at Peking University, where she serves as an Associate Professor. Her professional work spans various aspects of nursing education, including her involvement in the development and promotion of artificial intelligence-assisted learning methods. Sanli’s teaching excellence has been acknowledged through her role in managing and leading virtual and in-person simulation projects. These projects aim to improve the critical thinking and practical skills of undergraduate nursing students, setting a new standard for nursing education across China.

Sanli has also been actively involved in several key research initiatives, including the development of multimodal teaching methods for diseases of the urinary system and an in-depth study of nutrition-related symptoms in cancer patients undergoing radiotherapy. Through these contributions, she has gained recognition as a leading voice in nursing research and innovation, not only in China but also internationally.

Research and Contributions 📚

Sanli Jin’s research focuses primarily on three main areas: oncology and nutrition nursing, surgical nursing, and nursing simulation. Her contributions in these areas have significantly influenced both clinical practice and education. A key component of her research involves exploring the relationship between nutritional status and patient outcomes in oncology, particularly for patients with head and neck cancers. Her work in this domain has provided valuable insights into managing the complex nutritional needs of cancer patients, and she has earned awards for her research contributions, such as the Second Prize of the Beijing Nursing Society Science and Technology Award.

Another notable aspect of her work is in nursing simulation. Sanli has designed numerous simulation scenarios aimed at enhancing student learning, with her work receiving accolades such as the First Prize in the Case Group of the “Ninth Peking University Innovative Teaching and Learning Application Competition.” These contributions highlight her commitment to improving the quality of nursing education and equipping future nurses with the tools they need to succeed in complex clinical environments.

Accolades and Recognition 🏆

Over her career, Sanli Jin has been the recipient of multiple awards recognizing both her teaching excellence and her contributions to nursing research. Among her most notable accolades are:

  • National First Class Undergraduate Online Course: An award that highlights her contributions to the development of innovative, high-quality online nursing education.
  • Second Prize of the Beijing Nursing Society Science and Technology Award (Technical Achievement Award): Recognizing her work in the nutritional management of cancer patients.
  • Teaching Excellence Award from Peking University Health Science Center: A testament to her commitment to nursing education and student development.

In addition to these awards, Sanli has published nearly 100 papers in prominent national and international journals, further cementing her reputation as a researcher. Her work has garnered 389 citations and earned her an h-index of 11, showcasing the impact and influence of her research within the academic community.

Impact and Influence 🌍

Sanli Jin’s influence extends beyond her individual achievements in research and education. Her work in oncology nursing has had a profound impact on improving patient care, particularly for cancer patients undergoing radiotherapy. Through her research on nutrition and cancer, she has contributed to a better understanding of how dietary interventions can improve patient outcomes. Her efforts have also advanced simulation-based learning in nursing, bridging the gap between theoretical knowledge and practical skills for future generations of nurses.

Her leadership extends to various professional organizations as well. As a member of the MDT Professional Committee for Head and Neck Tumors and the Youth Committee for Cancer Rehabilitation and Nursing, Sanli actively collaborates with other professionals to push the boundaries of nursing science. These memberships allow her to continue influencing the field of oncology nursing, contributing to new standards and best practices.

Legacy and Future Contributions 🌱

Sanli Jin’s contributions have set a strong foundation for the future of nursing in China, particularly in the fields of oncology, nutrition, and nursing simulation. As a pioneer in incorporating artificial intelligence into nursing education, she has paved the way for future generations to embrace technology as a tool for enhancing both learning and patient care. Her ongoing research projects, such as the exploration of virtual simulation’s impact on nursing education, position her at the forefront of innovative teaching methods.

Her legacy is not just one of research and education but also of mentorship and leadership. Sanli has played a key role in nurturing the next generation of nurses and healthcare professionals, instilling in them the values of critical thinking, innovation, and compassion. Her commitment to advancing the field of nursing through both educational initiatives and patient care improvements ensures that her influence will continue to resonate for years to come.

Conclusion 📝

Sanli Jin’s academic and professional journey reflects a deep commitment to improving both nursing education and patient care. From her early academic pursuits to her innovative contributions in research and teaching, she has become a recognized leader in the field of nursing. Her work has not only earned her multiple prestigious awards but has also left a lasting impact on both her students and the broader nursing community. As she continues to explore new avenues of research and education, her legacy as a visionary in nursing will continue to grow, shaping the future of healthcare in China and beyond.

🎓Publication 

Evaluation of the combination of virtual simulation and in-person simulation among undergraduate nursing students: A mixed methods study

  • Authors   : Han, F., Jin, S.
  • Journal    :Nurse Education in Practice
  • Year         :2024

Body composition and dietary intake in patients with head and neck cancer during radiotherapy: A longitudinal study

  • Authors   :Zhuang, B., Zhang, L., Wang, Y., … Jin, S., Lu, Q.
  • Journal    :BMJ Supportive and Palliative Care,
  • Year         :2023

Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy

  • Authors   : Wang, Y., Zhang, L., Zhang, T., … Sun, Y., Lu, Q.
  • Journal    :Head and Neck
  • Year         :2023

Routine replacement versus replacement as clinical indicated of peripheral intravenous catheters: A multisite randomised controlled trial

  • Authors   : Li, J., Ding, Y., Lu, Q., … Lyu, Y., Lin, F.
  • Journal    :Journal of Clinical Nursing,
  • Year         :2023.

Association between body composition and survival in head and neck cancer patients undergoing radiotherapy

  • Authors   : Zhuang, B., Xiao, S., Zhang, L., … Sun, Y., Lu, Q.
  • Journal    :Head and Neck,
  • Year         :2022

Dr. Marc Bender|Immunotherapy |Best Researcher Award

Published on by Top Pharmaceutical

Dr. Marc Bender|Pharmaceutical Chemistry |Best Researcher Award|

Dr. Marc Bender at abriz University of Medical Sciences, Iran

PROFILE  

orcid

Early Academic Pursuits 📚

Marc Bender’s academic journey began with a strong foundation in molecular biology, earning a (link unavailable) and (link unavailable) from Universität Hamburg. He furthered his expertise by pursuing a doctorate in skin cancer research at the department of dermatology, Elbe Klinikum Buxtehude. His thesis focused on elucidating molecular mechanisms, particularly epigenetic regulation via miRNAs, involved in tumor progression of cutaneous squamous cell carcinoma.

Professional Endeavors 💼

As a data scientist, Marc contributed to the European melanoma registry (EUMelaReg), evaluating retrospective data for real-world clinical trials. This experience deepened his understanding of melanoma and immunotherapy, and he developed skills in statistical methods and programming. His professional endeavors have been marked by a commitment to advancing cancer research and treatment.

Contributions and Research Focus 🔬

Marc’s research focus encompasses various aspects of skin cancer, including:

– Investigating effects of combined UVA, UVB, visible light, and infrared radiation on human skin cells (KAUVIR)
– Examining the influence of UVA and UVB irradiation on human dermal stem cells (UV-DHDS)
– Comparing treatments for melanoma, including anti-PD1 monotherapy and BRAF/MEK inhibitor treatment (PDSeq and EMRSeq)
– Analyzing immune checkpoint inhibitor maintenance treatment after achieving a partial or complete response (EUMelaReg)

Accolades and Recognition 🏆

Marc’s work has been recognized through publications in esteemed journals, including:

– Journal of Cancer Research and Clinical Oncology
– Journal of Photochemistry and Photobiology B Biology
– Cancers (MDPI)
– Journal of Clinical Oncology (conference paper)
– Annals of Oncology (conference paper)

Impact and Influence 🌟

Marc’s research has contributed significantly to the understanding of skin cancer mechanisms and treatment options. His work has:

– Advanced knowledge of miRNA expression and its association with tumor progression
– Investigated treatment adherence in patients with stage III melanoma
– Compared outcomes of different treatment approaches for metastatic melanoma

Legacy and Future Contributions 🌱

As a dedicated researcher, Marc continues to contribute to the field of skin cancer research. His future endeavors will likely focus on:

– Furthering understanding of molecular mechanisms in skin cancer
– Developing innovative treatment approaches
– Collaborating with international researchers to advance cancer research

Marc’s legacy will be marked by his commitment to advancing cancer research, improving treatment options, and enhancing patient outcomes. His work will continue to influence the scientific community, inspiring future generations of researchers.

🎓Publication 

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

  • Authors   : Marc Bender
  • Journal    :Cancers
  • Year         :2022

UVB damage response of dermal stem cells as melanocyte precursors compared to keratinocytes, melanocytes, and fibroblasts from human foreskin

  • Authors   :Marc Bender
  • Journal    :Photochemistry and Photobiology B: Biology
  • Year         :2021

UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines

  • Authors   : Marc Bender
  • Journal    :Cancer Research and Clinical Oncologyy
  • Year         :2020

 

Assist Prof Dr. Ali Tavakoli|Oncology Pharmaceuticals|Best Researcher Award-1234

Published on by Top Pharmaceutical

Assist Prof Dr. Ali Tavakoli,Oncology Pharmaceutical,Best Researcher Award

Assist Prof Dr. Ali Tavakoli, at Shiraz University of Medical Sciences,Iran

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Dr. Ali Tavakoli embarked on his distinguished academic journey by earning his Medical Doctor (MD) degree from Shiraz University of Medical Sciences in Shiraz, Iran, in 1998. His early academic pursuits were marked by a profound interest in the complexities of the human body and the desire to contribute to medical science. This foundational phase was not just about acquiring knowledge but also about laying the groundwork for a career dedicated to improving health outcomes.

He continued his academic journey with a Master in Public Health (MPH) from the same institution in 2007. His MPH thesis, which focused on investigating risk factors of low birth weight in newborns, underlined his commitment to addressing public health issues. The meticulous work conducted under the supervision of Dr. Mohammad Hadi Imanieh showcased his analytical skills and dedication to maternal and child health.

🩺Professional Endeavors :

Dr. Tavakoli’s professional career has been a blend of clinical practice, administrative roles, and academic contributions. As an Assistant Professor in the Department of Persian Medicine at Shiraz University of Medical Sciences, he has been instrumental in advancing the field of traditional medicine. His role involves not only teaching but also mentoring students and conducting groundbreaking research.

Between May 2020 and November 2021, he served as the Advisor to the Chancellor of Shiraz University of Medical Sciences, a role that emphasized his leadership and strategic planning abilities. His involvement in significant projects, such as the national food security project in Zarrin Dasht County and the national MMR vaccination project, highlights his dedication to public health initiatives.

📚Contributions and Research Focus :

Dr. Tavakoli’s research has significantly contributed to various fields, including traditional Persian medicine, public health, and clinical trials. His Ph.D. thesis, supervised by Dr. Seyed Alireza Taghavi, evaluated the effect of Rose (Rosa damascena mill L) Oil Soft Capsules on clinical outcomes in ulcerative colitis, showcasing his innovative approach to integrating traditional remedies with modern clinical practices.

His extensive list of publications, including studies on the quality of work life and human resource productivity, the effects of medicinal plants on clinical conditions, and the efficacy of traditional treatments, reflects his diverse research interests and his ability to bridge traditional and modern medicine. Notable publications include:

  • “Efficacy of Rose Oil Soft Capsules on Clinical Outcomes in Ulcerative Colitis: A Pilot Randomized, Double-Blinded, Placebo-Controlled Clinical Trial” (Galen Medical Journal, 2019)
  • “COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study” (Iranian Journal of Medical Sciences, 2023)
  • “Efficacy of Plantago major leaf extract cream in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial” (European Journal of Integrative Medicine, 2023)

🏆Accolades and Recognition :

Dr. Tavakoli’s excellence has been recognized through various awards and honors. He was the top student in the Traditional Persian Medicine Ph.D. comprehensive exam at Shiraz University of Medical Sciences in 2014 and the top Ph.D. graduate in 2012. In 2010, he was awarded as the Annual Best Staff at Shiraz University of Medical Sciences, reflecting his outstanding contributions to the institution.

🌟Impact and Influence :

Dr. Tavakoli has had a profound impact on both his students and the broader medical community. His leadership roles, such as being a member of the Executive Committee of the Shiraz International mHealth Congress and his involvement with the Iranian Scientific Association of Traditional Medicine, have allowed him to influence the direction of medical research and public health policies.

🌍Legacy and Future Contributions :

Dr. Tavakoli’s legacy is characterized by his commitment to integrating traditional Persian medicine with contemporary clinical practices. His work has paved the way for future research in this field, promoting a holistic approach to healthcare. His ongoing research and publications continue to influence and inspire new generations of medical professionals.

In the future, Dr. Tavakoli aims to expand his research into the global applications of traditional Persian medicine, contributing to international medical knowledge and practices. His dedication to education, research, and public health ensures that his contributions will have a lasting impact on the medical community and beyond.

🎓Publication 

Reporting of adverse effects of pomegranate in clinical studies: a systematic review

  • Authors   :Hamid Zare, Ehsan Amiri Ardekani, Ali Tavakoli, Ryan Bradley, Fatemeh Tavakoli, Mehdi Pasalar
  • Journal    :Journal of Complementary and Integrative Medicine
  • Year         : 2024

Radiodermatitis in the field of traditional Persian medicine; a narrative review

    • Authors :Ghazaleh Heydarirad, Bahareh Ahadi, Ali Tavakoli, Hamid Reza Mirzaei, Mojgan Mehri Ardestani, Shaghayegh Kamian, Mehdi Pasalar
    • Journal   :Annals of the Romanian Society for Cell Biology
    • Year       : 2021

World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017

  • Authors  :, Kyung-Eun Choi, Lisha He, Han Wang, X He, C Gu, Y Zhang, Linhua Zhao, Xiaolin Tong, Lisha He, Han Wang, Xinhui He, Chengjuan Gu, Ying Zhang, Linhua Zhao, Xiaolin Tong, Lisha He
  • Journal    :BMC Complementary and Alternative Medicine
  • Year         :  2017

Efficacy of Plantago major leaf extract cream compared to placebo in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial

  • Authors  :Zahra Salehi, Ali Tavakoli, Seyed Hassan Hamedi, Soodabeh Samimi, Foroogh Namjooyan, Mansour Ansari, Hamid Nasrollahi, Nezhat Khanjani, Niloofar Ahmadloo, Ahmad Mosalaei, Behnam Kadkhodaei, Hossein Molavi Vardanjani, Mehrab Sayadi
  • Journal   :European Journal of Integrative Medicine
  • Year        :   2023

 

Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Authors  :Ghazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali TavakoliGhazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali Tavakoli
  • Journal   :Galen Medical Journal
  • Year        :   2021